SouthState’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
SouthState's VRTX Position: Q3 2026 in Review
SouthState increased its Vertex Pharmaceuticals (VRTX) stake by 4.4% in Q3 2026, buying an estimated $1.02K and bringing the position to 47 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #590.
SouthState first reported a position in VRTX in Q1 2024 and has held it in 11 quarters since. The position peaked at $62.1K in Q1 2025. 1,564 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- SouthState held 47 shares of Vertex Pharmaceuticals worth $24.6K as of Q3 2026.
- SouthState bought 2 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.02K.
- Vertex Pharmaceuticals made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #590 holding.
- SouthState first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
- SouthState's Vertex Pharmaceuticals position peaked at $62.1K in Q1 2025.
- 1,564 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.